Over the past 3 months, 4 analysts have published their opinion on Intercept Pharmaceuticals (NASDAQ:ICPT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
B of A Securities has decided to maintain its Neutral rating of Upstart Hldgs (NASDAQ:UPST) and lower its price target from $41.00 to $34.00.
Shares of Upstart Hldgs are trading down 20.72% over the last 24 hours, at $26.75 per share.
Keybanc has decided to maintain its Overweight rating of Materion (NYSE:MTRN) and lower its price target from $106.00 to $100.00.
Shares of Materion are trading up 0.58% over the last 24 hours, at $72.91 per share.
A move to $100.00 would account for a 37.16% increase from the current share price.
Citigroup has decided to maintain its Neutral rating of Illumina (NASDAQ:ILMN) and lower its price target from $325.00 to $220.00.
Shares of Illumina are trading up 0.17% over the last 24 hours, at $202.54 per share.
A move to $220.00 would account for a 8.62% increase from the current share price.
Wells Fargo downgraded its rating of Clear Channel Outdoor (NYSE:CCO) to Equal-Weight with a price target of $1.50, changing its price target from $4.00 to $1.50.
Shares of Clear Channel Outdoor are trading down 5.12% over the last 24 hours, at $1.21 per share.